tiprankstipranks
Evogene Ltd. (EVGN)
:EVGN
US Market

Evogene (EVGN) Income Statement

Compare
584 Followers

Evogene Income Statement

Last quarter (Q3 2024), Evogene's total revenue was $1.80M, a decrease of -52.32% from the same quarter last year. In Q3, Evogene's net income was $-7.63M. See Evogene’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 5.64M$ 1.68M$ 930.00K$ 1.04M$ 753.00K
Gross Profit
$ 1.40M$ 766.00K$ 163.00K$ 466.00K$ 419.00K
Operating Expenses
$ 27.79M$ 27.71M$ 31.12M$ 25.28M$ 21.59M
Depreciation and Amortization
$ 2.61M$ 2.58M$ 2.23M$ 2.73M$ 2.77M
EBITDA
$ -23.20M$ -26.93M$ -27.80M$ -23.18M$ -15.97M
Operating Income
$ -26.39M$ -26.94M$ -30.95M$ -24.81M$ -21.17M
Other Income/Expenses
$ 404.00K$ 687.00K$ 521.00K$ -1.36M$ 2.08M
Pretax Income
$ -25.99M$ -29.75M$ -30.43M$ -26.17M$ -19.09M
Net Income
$ -23.88M$ -26.64M$ -27.79M$ -23.37M$ -18.11M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -5.23$ -6.46$ -6.87$ -8.30$ -0.70
Diluted EPS
$ -5.23$ -6.46$ -6.87$ -8.30$ -0.70
Weighted Average Shares Outstanding
4.57M 4.12M 4.04M 2.82M 25.75M
Weighted Average Shares Outstanding (Diluted)
4.57M 4.12M 4.04M 2.82M 25.75M
Currency in USD

Evogene Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis